Panbio Inc Company Profile

07:52 EST 13th December 2018 | BioPortfolio

Established in 1988 and listed on the Australian Stock Exchange in 2001, Panbio Limited is an Australian-based international diagnostics company. With a mission of “better tests for more people”, the Company develops, manufactures and markets innovative diagnostic tests to aid in the diagnosis of infectious disease. The Company is recognized as a world leader in tests used in the diagnosis of flavivirus and other arthropod-borne virusesWith a product portfolio covering over 30 infectious diseases, the company supports pathology laboratories and physicians in Australia, Asia, the Americas, Europe, the Middle East and Africa.
Panbio has a history of market leadership in response to diseases that afflict millions of people and was ‘first to market’ with diagnostics for dengue fever, Ross River fever and West Nile encephalitis.
Its range of technical platforms includes enzyme-linked immunosorbent assay (ELISA), indirect fluorescent antibody test (IFA) and rapid lateral flow devices.
The Company’s strategic partnerships include customers, distributors, other manufacturers and some of the world’s leading research organisations.
In the past year, Panbio received US FDA clearance for its second generation West Nile virus test, received the first orders for its new Dengue ‘Point of Care’ cassette and signed research agreements to develop improved diagnostics for Japanese encephalitis, leptospirosis and malaria.
In research, Panbio is pursuing two significant improvements in the development of in vitro diagnostic assays.
The first involves a two-year project to develop a novel homogeneous assay for the diagnostics market. If successful, clinical diagnostic tests that currently require up to three hours will be processed in a matter of minutes – a dramatic breakthrough by Panbio.


9075 Guilford Road
United States of America


Phone: 1 410 381 8550
Fax: 1 410 381 8984

News Articles [0 Results]


Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [1 Associated Companies listed on BioPortfolio]

Panbio Inc

Established in 1988 and listed on the Australian Stock Exchange in 2001, Panbio Limited is an Australian-based international diagnostics company. With a mission of “better tests for more people”,...

More Information about "Panbio Inc" on BioPortfolio

We have published hundreds of Panbio Inc news stories on BioPortfolio along with dozens of Panbio Inc Clinical Trials and PubMed Articles about Panbio Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Panbio Inc Companies in our database. You can also find out about relevant Panbio Inc Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...

Corporate Database Quicklinks

Searches Linking to this Company Record